S100 TREATMENT-DEPENDENCE OF HIGH-RISK GENE EXPRESSION SIGNATURES IN DE NOVO FOLLICULAR LYMPHOMA Bolen, C.; Hiddemann, W.; Marcus, R.; More Bolen, C.; Hiddemann, W.; Marcus, R.; Herold, M.; Huet, S.; Salles, G.; Mattiello, F.; Nielsen, T.; Mir, F.; Venstrom, J. M.; Oestergaard, M.Z. Less HemaSphere. 3(S1):1, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S101 EFFICACY AND SAFETY OF PROLONGED MAINTENANCE WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA: RESULTS OF THE PHASE III MABCUTE STUDY Rule, S.; Gois Barreto, W.; Briones, J.; More Rule, S.; Gois Barreto, W.; Briones, J.; Carella, A.M.; Pocock, C.; Wendtner, C.-M.; Zaja, F.; Robson, S.; Tschopp, R. R.; Dreyling, M. Less HemaSphere. 3(S1):1, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S102 POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) AND LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): INTERIM ANALYSIS OF A PHASE IB/II TRIAL Abrisqueta, P.; Kahl, B.; Banerjee, L.; More Abrisqueta, P.; Kahl, B.; Banerjee, L.; McMillan, A.; Ramchandren, R.; Miall, F.; Briones, J.; Cordoba, R.; Gonzalez-Barca, E.; Panizo, C.; Hirata, J.; Chang, N.; Musick, L.; Diefenbach, C. Less HemaSphere. 3(S1):2-3, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S103 OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS, LYMA-101 TRIAL - A LYSA TRIAL Legouill, S.; Beldi-Ferchiou, A.; Cacheux, V.; More Legouill, S.; Beldi-Ferchiou, A.; Cacheux, V.; Alcantara, M.; Salles, G.; Canioni, D.; Bodet-Milin, C.; Delwail, V.; Gastinne, T.; thieblemont, C.; Moles, M.-P.; Damaj, G.; Jaccard, A.; Daguindau, N.; Ribrag, V.; Delfau-Larue, M.-H.; Macintyre, E.; Hermine, O. Less HemaSphere. 3(S1):3, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S104 THE BRAF INHIBITOR VEMURAFENIB COMBINED WITH RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE REMISSIONS IN RELAPSED OR REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE-2 TRIAL Tiacci, E.; De Carolis, L.; Simonetti, E.; More Tiacci, E.; De Carolis, L.; Simonetti, E.; Zaja, F.; Capponi, M.; Ambrosetti, A.; Lucia, E.; Antolino, A.; Pulsoni, A.; Ferrari, S.; Zinzani, P. L.; Rigacci, L.; Gaidano, G.; Della Seta, R.; Frattarelli, N.; Falcucci, P.; Visani, G.; Foà, R.; Falini, B. Less HemaSphere. 3(S1):3, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S105 GENETIC MARKERS AND OUTCOME IN THE CLL14 TRIAL OF THE GCLLSG COMPARING FRONT LINE OBINUTUZUMAB PLUS CHLORAMBUCIL OR VENETOCLAX IN PATIENTS WITH COMORBIDITY Tausch, E.; Bahlo, J.; Robrecht, S.; More Tausch, E.; Bahlo, J.; Robrecht, S.; Schneider, C.; Bloehdorn, J.; Schrell, S.; Galler, C.; Al-Sawaf, O.; Fink, A.-M.; Eichhorst, B.; Kreuzer, K.-A.; Tandon, M.; Humphrey, K.; Jiang, Y.; Schary, W.; Porro Lurà, M.; Döhner, H.; Fischer, K.; Hallek, M.; Stilgenbauer, S. Less HemaSphere. 3(S1):4, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S106 HIGH EFFICACY OF VENETOCLAX PLUS OBINUTUZUMAB IN PATIENTS WITH COMPLEX KARYOTYPE (CKT) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A PROSPECTIVE ANALYSIS FROM THE CLL14 TRIAL Al-Sawaf, O.; Lilienweiss, E.; Bahlo, J.; More Al-Sawaf, O.; Lilienweiss, E.; Bahlo, J.; Robrecht, S.; Fink, A.-M.; Patz, M.; Tandon, M.; Humphrey, K.; Jiang, Y.; Schary, W.L.; Porro Lurà, M.; Ritgen, M.; Tasch, E.; Stilgenbauer, S.; Eichhorst, B.; Fischer, K.; Hallek, M.; Kreuzer, K.-A. Less HemaSphere. 3(S1):4-5, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S107 FIVE-YEAR FOLLOW-UP OF PATIENTS RECEIVING IBRUTINIB FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA Tedeschi, A.; Burger, J.; Barr, P.M.; More Tedeschi, A.; Burger, J.; Barr, P.M.; Robak, T.; Owen, C.; Ghia, P.; Bairey, O.; Hillmen, P.; Coutre, S.; Devereux, S.; Grosicki, S.; McCarthy, H.; Li, J.; Simpson, D.; Offner, F.; Moreno, C.; Dai, S.; Lal, I.; Dean, J.P.; Kipps, T.J. Less HemaSphere. 3(S1):5-6, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S108 SAFETY ANALYSIS OF VENETOCLAX AND IBRUTINIB FOR PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL): SECOND INTERIM ANALYSIS FROM THE PHASE II VISION HO141 TRIAL Kater, A.P.; Dubois, J.; Kersting, S.; More Kater, A.P.; Dubois, J.; Kersting, S.; Enggaard, L.; Veldhuis, G.J.; Mous, R.; Mellink, C.H.; Dobber, J.A.; Poulsen, C.B.; Frederiksen, H.; Janssens, A.; Janssen, S.R.; Schjødt, I.; Dompeling, E.C.; Salmi, T.; Mattsson, M.; Bellido, M.; Tran, H.T.; Nasserinejad, K.; Levin, M.-D.; Niemann, C.U. Less HemaSphere. 3(S1):6, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S109 TRANSCEND CLL 004: MINIMAL RESIDUAL DISEASE NEGATIVE RESPONSES AFTER LISOCABTAGENE MARALEUCEL (LISO-CEL) IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA Siddiqi, T.; Dorritie, K.; Soumerai, J.; More Siddiqi, T.; Dorritie, K.; Soumerai, J.; Stephens, D.; Dubovsky, J.; Gillenwater, H.; Gong, L.; Thorpe, J.; Yang, L.; Wierda, W. Less HemaSphere. 3(S1):6-7, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S110 SCREENING OF CLUSTERED REGULATORY ELEMENTS REVEALS NOVEL LEUKEMIA DEPENDENCIES Benbarche, S.; Lopez, C.; Salataj, E.; More Benbarche, S.; Lopez, C.; Salataj, E.; chaumeil, J.; Mercher, T.; Lobry, C. Less HemaSphere. 3(S1):7, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S111 SIRT5 IS REQUIRED FOR ACUTE MYELOID LEUKEMIA GROWTH AND SURVIVAL AND MAY REPRESENT A NOVEL THERAPEUTIC TARGET Yan, D.; Franzini, A.; Mason, C.; More Yan, D.; Franzini, A.; Mason, C.; Ahmann, J.; Heaton, W.; Clair, P.; Senina, A.; Halvorsen, B.; Than, H.; Khorashad, J.; Jones, C.; Pomicter, A.; O’Hare, T.; Deininger, M. Less HemaSphere. 3(S1):8, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S112 MLL FUSIONS AFFECT SPLICING TO INDUCE EXPLOITABLE METABOLIC DEPENDENCIES Garcia-Cuellar, M.-P.; Lawlor, J.; Böttcher, M.; More Garcia-Cuellar, M.-P.; Lawlor, J.; Böttcher, M.; Mougiakakos, D.; Slany, R. Less HemaSphere. 3(S1):8, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S113 GENETICS AND MODELING OF HUMAN ACUTE ERYTHROID LEUKEMIA Fagnan, A.; Riera Piqué Borràs, M.; Ignacimouttou, C.; More Fagnan, A.; Riera Piqué Borràs, M.; Ignacimouttou, C.; Otzen Bagger, F.; Lopez, C.K.; Caulier, A.; Aid, Z.; Thirant, C.; kurtovic, A.; Maciejewski, J.; Dierks, C.; Rambaldi, A.; Pabst, T.; Shimoda, K.; Lapillonne, H.; DeBotton, S.; Micoll, J.-B.; Caroll, M.; Valent, P.; Kile, B.; Carmichael, C.; Vyas, P.; Delabesse, E.; Gelsi-Boyer, V.; Birnbaum, D.; Anguita, E.; Garcon, L.; Soler, E.; Schwaller, J.; Mercher, T. Less HemaSphere. 3(S1):8-9, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S114 POST-TRANSPLANT CYCLOPHOSPHAMIDE VS ATG FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN T-REPLETE HAPLOIDENTICAL TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT OF THE ALWP/EBMT Nagler, A.; Labopin, M.; Ruggeri, A.; More Nagler, A.; Labopin, M.; Ruggeri, A.; Ciceri, F.; Sanz, J.; Angelucci, E.; Koc, Y.; Gülbas, Z.; Arcese, W.; Tischer, J.; Pioltelli, P.; Ozdogu, H.; Afanasyev, B.; Wu, D.; Arat, M.; Peric, Z.; Giebel, S.; Mohty, M. Less HemaSphere. 3(S1):9, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S115 IMPACT OF MESURABLE RESIDUAL DISEASE POSITIVITY ON OUTCOMES FOLLOWING UNMBILICAL CORD BLOOD TRANSPLANTATION: A STUDY FROM THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT AND EUROCORD Baron, F.; Labopin, M.; Ruggeri, A.; More Baron, F.; Labopin, M.; Ruggeri, A.; Sierra, J.; Robinson, S.; Labussière-Wallet, H.; Potter, M.; Ribera Santasusana, J. M.; Deconinck, E.; Rambaldi, A.; Rohrlich, P.-S.; de Revel, T.; Gluckman, E.; Nagler, A.; Mohty, M. Less HemaSphere. 3(S1):9-10, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S116 A BUSULFAN FOLLOWING CYCLOPHOSPHAMIDE, PROTOCOL IMPROVED RESULTS IN ALTERNATIVE DONOR TRANSPLANT FOR PATIENTS WITH THALASSEMIA MAJOR: A RESULT FROM LONG-TERM LARGE-SIZE MULTI-CENTER STUDY IN CHINA Li, C.; He, Y.; Jiang, H.; More Li, C.; He, Y.; Jiang, H.; Li, C.; Zhu, Y.; Wu, X.; Liu, S.; Liao, J.; Feng, X.; Liu, H.; Peng, Z.; Yang, X. Less HemaSphere. 3(S1):10, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S117 THE ROLE OF ANTI-THYMOCYTE GLOBULIN WITH THIOTEPA-BUSULFAN-FLUDARABINE BASED CONDITIONING IN PATIENTS UNDERGOING HAPLOIDENTICAL STEM CELL TRANSPLANT AND POST-TRANSPLANT CYCLOPHOSPHAMIDE El-Cheikh, J.; Devillier, R.; Dulery, R.; More El-Cheikh, J.; Devillier, R.; Dulery, R.; Massoud, R.; Moukalled, N.; Ghaoui, N.; Pagliardini, T.; Marino, F.; Bazarbachi, A.; Castagna, L.; Mohty, M.; Blaise, D. Less HemaSphere. 3(S1):10-11, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S118 IMPACT OF PRE-TRANSPLANT DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN CORD BLOOD TRANSPLANTATION ON BEHALF OF THE TRANSPLANT COMPLICATIONS WORKING GROUP OF JSHCT Fuji, S.; Oshima, K.; Ohashi, K.; More Fuji, S.; Oshima, K.; Ohashi, K.; Sawa, M.; Saito, K.; Eto, T.; Tanaka, M.; Onizuka, M.; Nakamae, H.; Shiratori, S.; Ozawa, Y.; Hidaka, M.; Nagamura-Inoue, T.; Tanaka, H.; Fukuda, T.; Ichinohe, T.; Atsuta, Y.; Ogata, M. Less HemaSphere. 3(S1):11, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S119 THE ROLE OF RECURRENT SOMATIC ALTERATIONS IN THE NON-CODING GENOME WITH FUNCTIONAL IMPLICATIONS IN MM Samur, M.; Szalat, R.; Aktas Samur, A.; More Samur, M.; Szalat, R.; Aktas Samur, A.; Fulciniti, M.; Lopez, M.; Shammas, M.; Richardson, P.; Magrangeas, F.; Minvielle, S.; Moreau, P.; Attal, M.; Thakurta, A.; Anderson, K.; Parmigiani, G.; Avet-Loiseau, H.; Munshi, N. Less HemaSphere. 3(S1):11-12, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S120 CHRONOLOGY OF COPY NUMBER ALTERATIONS FROM PRECURSORS TO MULTIPLE MYELOMA: WHAT COMES FIRST? Aktas Samur, A.; Minvielle, S.; Fulciniti, M.; More Aktas Samur, A.; Minvielle, S.; Fulciniti, M.; Szalat, R.; Shammas, M.; Magrangeas, F.; Moreau, P.; Attal, M.; Anderson, K.; Parmigiani, G.; Avet-Loiseau, H.; Munshi, N.; Samur, M. Less HemaSphere. 3(S1):12, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S121 SINGLE-CELL CHARACTERIZATION OF THE MULTIPLE MYELOMA (MM) IMMUNE MICROENVIRONMENT IDENTIFIES CD27- T CELLS AS POTENTIAL SOURCE OF TUMOR-REACTIVE LYMPHOCYTES Botta, C.; Perez, C.; Puig, N.; More Botta, C.; Perez, C.; Puig, N.; Cedena, M.T.; Cordon, L.; Zabaleta, A.; Burgos, L.; Maia, C.; Goicoechea, I.; Rodriguez, S.; Rodriguez, I.; Sarvide, S.; Alignani, D.; Vilas-Zornoza, A.; Lorenzo-Vivas, E.; Rosiñol, L.; Oriol, A.; Blanchard, M.-J.; Rios, R.; Sureda, A.; Martinez, R.; Martin, J.; Bargay, J.; de la Rubia, J.; Rossi, M.; Tagliaferri, P.; Tassone, P.; Merino, J.; Prosper, F.; Orfao, A.; Mateos, M.-V.; Lahuerta, J.-J.; Bladé, J.; San Miguel, J.; Paiva, B. Less HemaSphere. 3(S1):12-13, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S122 THE FIRST-IN-CLASS, ORALLY AVAILABLE BMI-1 MODULATORS PTC-028 AND PTC596 DISPLAY POTENT ACTIVITY IN PRE-CLINICAL MODELS OF MULTIPLE MYELOMA Bolomsky, A.; Muller, J.; Stangelberger, K.; More Bolomsky, A.; Muller, J.; Stangelberger, K.; Lejeune, M.; Arnold, D.; Duray, E.; Breid, H.; Vrancken, L.; Hübl, W.; Willheim, M.; Weetall, M.; Branstrom, A.; Zojer, N.; Caers, J.; Ludwig, H. Less HemaSphere. 3(S1):13, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S123 SETD2 LOSS OF FUNCTION IS A RECURRENT EVENT IN ADVANCED-PHASE CHRONIC MYELOID LEUKEMIA INDUCED BY POST-TRANSLATIONAL MECHANISMS THAT CAN BE THERAPEUTICALLY TARGETED Mancini, M.; De Santis, S.; Monaldi, C.; More Mancini, M.; De Santis, S.; Monaldi, C.; Bavaro, L.; Martelli, M.; Castagnetti, F.; Gugliotta, G.; Rosti, G.; Fontana, M.C.; Dan, E.; Sinigallia, B.; Iurlo, A.; Orofino, N.; Abbruzzese, E.; Salvucci, M.; Pregno, P.; Gozzini, A.; Crugnola, M.; Albano, F.; Bonifacio, M.; Calistri, E.; Tiribelli, M.; Binotto, G.; Imovilli, A.; Trabacchi, E.; Galimberti, S.; Baratè, C.; Tenti, E.; Baccarani, M.; Martinelli, G.; Cavo, M.; Soverini, S. Less HemaSphere. 3(S1):13-14, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S124 IDENTIFICATION OF THE DOPAMINE AND SEROTONIN TRANSPORTERS SLC6A3 AND SLC6A4 AS NOVEL SURVIVAL FACTORS IN LEUKEMIC STEM CELLS IN CHRONIC MYELOID LEUKAEMIA Aldosari, A.; Ritchie, J.; Calvo-Sánchez, J.; More Aldosari, A.; Ritchie, J.; Calvo-Sánchez, J.; Hewit, K.; James, D.; Dunn, K.; Copland, M.; Holyoake, T.; Shanks, E.; Scott, M.; Vetrie, D. Less HemaSphere. 3(S1):14, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S125 PATHWAY AND GENE SET OVERDISPERSION ANALYSIS OF SINGLE CELL TRANSCRIPTOMIC DATA FROM PATIENTS WITH CHRONIC MYELOID LEUKAEMIA HIGHLIGHTS TRANSCRIPTIONAL HETEROGENEITY IN CD34+CD38- CELLS Dunn, W.; Hopcroft, L. Dunn, W.; Hopcroft, L. Less HemaSphere. 3(S1):14-15, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S126 COMBINATION OF ASCIMINIB (ABL001) WITH ATP-COMPETITIVE TYROSINE KINASE INHIBITORS TARGETS EARLY CML PROGENITOR CELLS. Munje, C.; Hyde, R.; Kinstrie, R.; More Munje, C.; Hyde, R.; Kinstrie, R.; Mitchell, R.; Scott, M.; Helgason, V.; Jorgensen, H.; Vetrie, D.; Copland, M. Less HemaSphere. 3(S1):15, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S127 CHRONIC MYELOID LEUKEMIA IS ASSOCIATED WITH INCREASED NEUTROPHIL EXTRACELLULAR TRAP FORMATION THAT IS AUGMENTED BY PONATINIB – A POTENTIAL CONTRIBUTOR TO VASCULAR TOXICITY? Telerman, A.; Granot, G.; Shacham-Abulafia, A.; More Telerman, A.; Granot, G.; Shacham-Abulafia, A.; Ellis, M.H.; Yarchovsky-Dolberg, O.; Raanani, P.; Wolach, O. Less HemaSphere. 3(S1):15-16, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S128 BCP- AND T-ALL CELLS HIDE IN DISTINCT NICHES OF THE BONE MARROW Capron, D.; Zuchtriegel, G.; Behrmann, L.; More Capron, D.; Zuchtriegel, G.; Behrmann, L.; Kunz, L.; Marovca, B.; Kirschmann, M.; Nombela-Arrieta, C.; Suessbier, U.; Ziegler, U.; Schroeder, T.; Bornhauser, B.; Bourquin, J.-P. Less HemaSphere. 3(S1):16, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S129 TP53 SOMATIC MUTATIONS AS PRE-LEUKEMIC EVENTS IN ACUTE LYMPHOBLASTIC LEUKEMIA Chitadze, G.; Stengel, A.; John-Klaua, C.; More Chitadze, G.; Stengel, A.; John-Klaua, C.; Trautmann, H.; knecht, H.; Schwarz, M.; Kotrova, M.; Hollmann, J.; Hermann, D.; Appelt, F.; Theocharis, T.; Pal, K.; Darzentas, N.; Oberg, H.-H.; Kabelitz, D.; Gökbuget, N.; Baldus, C.; Haferlach, C.; Brüggemann, M. Less HemaSphere. 3(S1):16-17, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S130 TRANSIENT SUBCLONES CARRYING NT5C2 MUTATIONS DEFINE A HIGH-RISK PATIENT GROUP WITH POOR OUTCOME IN PEDIATRIC RELAPSED B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA Pogodzinski, M.J.; Hof, J.; Groeneveld-Krentz, S.; More Pogodzinski, M.J.; Hof, J.; Groeneveld-Krentz, S.; Szymansky, A.; von Stackelberg, A.; Ferrando, A.A.; Eckert, C.; Kirschner-Schwabe, R. Less HemaSphere. 3(S1):17, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S131 IL7R EXPRESSION PREDICTS T-ALL SENSITIVITY TO JAK INHIBITORS REGARDLESS OF IL7R/JAK/STAT MUTATIONAL STATUS Kim, R.; Tueur, G.; Delecourt, M.; More Kim, R.; Tueur, G.; Delecourt, M.; Boissel, N.; Feroul, M.; Latiri, M.; Vilarese, P.; Hippolyte, G.; Tesio, M.; Andrieu, G.; Ifrah, N.; Petit, A.; Dombret, H.; Macintyre, E.; Asnafi, V.; Lhermitte, L. Less HemaSphere. 3(S1):17-18, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S132 BIOLOGICAL CHARACTERIZATION OF THE U2AF1 S34F MUTATION IN THE PATHOGENESIS OF MYELODYSPLASIA Kon, A.; Nannya, Y.; Kataoka, K.; More Kon, A.; Nannya, Y.; Kataoka, K.; Nakayama, M.; Koseki, H.; Sanada, M.; Makishima, H.; Nakagawa, M.M.; Ogawa, S. Less HemaSphere. 3(S1):19, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S133 EX VIVO DRUG SENSITIVITY PROFILING IN MYELODYSPLASTIC SYNDROME (MDS) PATIENTS DEFINES NOVEL DRUG SENSITIVITY PATTERNS FOR PREDICTING CLINICAL THERAPEUTIC OUTCOMES Aleshin, A.; Santaguida, M.T.; Schaffert, S.A.; More Aleshin, A.; Santaguida, M.T.; Schaffert, S.A.; Spinner, M.A.; Sanders, J.N.; Zehnder, J.; Patterson, A.S.; Heiser, D.; Greenberg, P.L. Less HemaSphere. 3(S1):19, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S134 CLONAL HEMATOPOIESIS IN ELDERLY TWINS: CONCORDANCE, DISCORDANCE AND SURVIVAL Hansen, J.W.; Pedersen, D.A.; Larsen, L.A.; More Hansen, J.W.; Pedersen, D.A.; Larsen, L.A.; Husby, S.; Favero, F.; Weischenfeldt, J.; Christensen, K.; Grønbæk, K. Less HemaSphere. 3(S1):19, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S135 NGS-BASED COPY-NUMBER ANALYSIS IN MORE THAN 2,000 PATIENTS WITH MYELOID NEOPLASMS Saiki, R.; Shiozawa, Y.; Yoshizato, T.; More Saiki, R.; Shiozawa, Y.; Yoshizato, T.; Nanya, Y.; Takeda, J.; Yoshida, K.; Shiraishi, Y.; Tanaka, H.; Chiba, K.; Atsuta, Y.; Onizuka, M.; Itonaga, H.; Sanada, M.; Kanda, Y.; Przychodzen, B.; Sekeres, M.A.; Guinta, K.M.; Saunthararajah, Y.; Shih, L.-Y.; Miyawaki, S.; Nakamaki, T.; Taguchi, M.; Fuji, S.; Sasaki, N.; Uoshima, N.; Ueda, Y.; Miyazaki, Y.; Usuki, K.; Imada, K.; Takaori-Kondo, A.; Chiba, S.; Kasahara, S.; Kiguchi, T.; Tsurumi, H.; Malcovati, L.; Cazzola, M.; Ishikawa, T.; Miyano, S.; Maciejewski, J.P.; Makishima, H.; Ogawa, S. Less HemaSphere. 3(S1):19-20, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S136 REPROGRAMMING HEMATOPOIETIC STEM CELL FUNCTION VIA MODULATION OF MITOCHONDRIAL ACTIVITY Girotra, M.; Rincon-Restrepo, M.; Oggier, A.; More Girotra, M.; Rincon-Restrepo, M.; Oggier, A.; Coukos, G.; Naveiras, O.; Rezzi, S.; Vannini, N. Less HemaSphere. 3(S1):20, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S137 DNA METHYLATION DYNAMICS IDENTIFY LINEAGE-SPECIFIC REGULATION PATTERNS OF HEMATOPOIETIC DIFFERENTIATION Stäble, S.; Krämer, S.; Langstein, J.; More Stäble, S.; Krämer, S.; Langstein, J.; Bogeska, R.; Hartmann, M.; Schönung, M.; Anstee, N.; Haas, S.; Weichenhan, D.; Czeh, M.; Gräsel, J.; Hübschmann, D.; Rosenbauer, F.; Plass, C.; Schlesner, M.; Milsom, M.; Lipka, D. Less HemaSphere. 3(S1):20, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S138 A DISTINCT WAVE OF HSC-DERIVED T CELL-ILC-RESTRICTED PROGENITORS INITIATES THE EMBRYONIC THYMUS Elsaid, R.; Yang, J.; Iturri, L.; More Elsaid, R.; Yang, J.; Iturri, L.; Rodewald, H.-R.; Perdiguero, E.G.; Cumano, A. Less HemaSphere. 3(S1):20-21, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S139 JUNCTIONAL ADHESION MOLECULE A (JAM-A) IS A CRITICAL REGULATOR OF HSC HOMING AND MAINTENANCE OF STEM CELL QUIESCENCE Cao, B.; Hart, C.; Iberl, S.; More Cao, B.; Hart, C.; Iberl, S.; Müller, G.; Williams, B.; Heazlewood, S.; Domingues, M.; Vinson, A.; Sun, X.; Li, S.; Heazlewood, C.; Pritchard, C.; Haylock, D.; Nefzger, C.; Polo, J.; Schelker, R.; Herr, W.; Martin-Padura, I.; Grassinger, J.; Nilsson, S. Less HemaSphere. 3(S1):21, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S140 RESULTS FROM THE PHASE 3 NORTHSTAR-3 STUDY EVALUATING LENTIGLOBIN GENE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSAEMIA AND A β0 OR IVS-I-110 MUTATION AT BOTH ALLELES OF THE HBB GENE Kulozik, A.E.; Locatelli, F.; Yannaki, E.; More Kulozik, A.E.; Locatelli, F.; Yannaki, E.; Porter, J.B.; Thuret, I.; Sauer, M.G.; Lal, A.; Kwiatkowski, J.L.; Elliot, H.; Tao, G.; Colvin, R.A.; Thompson, A.A. Less HemaSphere. 3(S1):21-22, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S141 CLINICAL OUTCOMES OF LENTIGLOBIN GENE THERAPY FOR TRANSFUSION-DEPENDENT β-THALASSAEMIA (TDT) FOLLOWING COMPLETION OF THE NORTHSTAR (HGB-204) STUDY Walters, M.C.; Kwiatkowski, J.L.; Rasko, J.E.J.; More Walters, M.C.; Kwiatkowski, J.L.; Rasko, J.E.J.; Hongeng, S.; Schiller, G.J.; Anurathapan, U.; Cavazzana, M.; Ho, P.J.; Schmidt, M.; Kletzel, M.; Leboulch, P.; Vichinsky, E.; Deary, B.; Chen, Y.; Petrusich, A.; Thompson, A.A. Less HemaSphere. 3(S1):22, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S142 FIRST-IN-CLASS ORAL FERROPORTIN INHIBITOR: MODE OF ACTION AND EFFICACY IN A MOUSE MODEL OF BETA-THALASSEMIA INTERMEDIA Manolova, V.; Nyffenegger, N.; Flace, A.; More Manolova, V.; Nyffenegger, N.; Flace, A.; Altermatt, P.; Doucerain, C.; Sundström, H.; Dürrenberger, F. Less HemaSphere. 3(S1):22-23, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S143 LUSPATERCEPT INCREASES FETAL HEMOGLOBIN (HBF) LEVELS IN ADULT β-THALASSEMIA PATIENTS WHO REQUIRE RED BLOOD CELL (RBC) TRANSFUSIONS Cappellini, M.-D.; Schwickart, M.; Hermine, O.; More Cappellini, M.-D.; Schwickart, M.; Hermine, O.; Piga, A.; Risueño, A.; Acar, M.; Zinger, T.; Laadem, A.; Shetty, J.; Morison, J.; Miteva, D.; MacBeth, K.; Taher, A. Less HemaSphere. 3(S1):23, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S144 A MULTICENTRE, RANDOMIZED, NON-INFERIORITY TRIAL COMPARING THE EFFICACY OF DEFERIPRONE VERSUS DEFERASIROX IN PEDIATRIC PATIENTS AFFECTED BY TRANSFUSION-DEPENDENT HEMOGLOBINOPATHIES (DEEP-2 TRIAL) Kattamis, A.; Felisi, M.; Reggiardo, G.; More Kattamis, A.; Felisi, M.; Reggiardo, G.; El-Beshlawy, A.; Bejaoui, M.; Sherief, L.; Christou, S.; Cosmi, C.; Della Pasqua, O.; Del Vecchio, G.C.; Filosa, A.; Hassab, H.; Kreka, M.; Origa, R.; Putti, M.C.; Spino, M.; Telfer, P.; Tempesta, B.; Tsang, Y.C.; Zaka, A.; Tricta, F.; Bonifazi, D.; Ceci, A.; Maggio, A. Less HemaSphere. 3(S1):23-24, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S145 PHASE 3 RANDOMIZED STUDY OF DARATUMUMAB + BORTEZOMIB/THALIDOMIDE/DEXAMETHASONE (D-VTD) VERSUS VTD IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: PART 1 CASSIOPEIA RESULTS Moreau, P.; Attal, M.; Hulin, C.; More Moreau, P.; Attal, M.; Hulin, C.; Arnulf, B.; Belhadj, K.; Benboubker, L.; Béné, M. C.; Broijl, A.; Caillon, H.; Caillot, D.; Corre, J.; Delforge, M.; Dejoie, T.; Doyen, C.; Facon, T.; Sonntag, C.; Garderet, L.; Jie, K.-S.; Karlin, L.; Kuhnowski, F.; Lambert, J.; Leleu, X.; Lenain, P.; Macro, M.; Orsini-Piocelle, F.; Perrot, A.; Stoppa, A.-M.; van de Donk, N. W.; Wuilleme, S.; Zweegman, S.; Kolb, B.; Touzeau, C.; Roussel, M.; Tiab, M.; Marolleau, J.-P.; Meuleman, N.; Vekemans, M.-C.; Westerman, M.; Klein, S. K.; Levin, M.-D.; Escoffre-Barbe, M.; Eveillard, J.-R.; Garidi, R.; Ahmadi, T.; Zhuang, S.; Chiu, C.; Pei, L.; Vanquickelberghe, V.; de Boer, C.; Smith, E.; Deraedt, W.; Kampfenkel, T.; Schecter, J.; Vermeulen, J.; Avet-Loiseau, H.; Sonneveld, P. Less HemaSphere. 3(S1):24-25, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S146 DECIPHERING THE ROLE OF RUNX1 ISOFORMS IN THE DEVELOPMENT OF TRANSIENT ABNORMAL MYELOPOIESIS Gialesaki, S.; Labuhn, M.; Bräuer-Hartmann, D.; More Gialesaki, S.; Labuhn, M.; Bräuer-Hartmann, D.; Matzk, S.; Strüwe, F.-J.; Kadel, S.-K.; Schmid, L.; Amstislavskiy, V.; Risch, T.; Yaspo, M.-L.; Heckl, D.; Klusmann, J.-H. Less HemaSphere. 3(S1):25, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S147 RESULTS FROM THE RANDOMIZED PLACEBO-CONTROLLED PHASE 3 HOPE TRIAL OF VOXELOTOR IN ADULTS AND ADOLESCENTS WITH SICKLE CELL DISEASE Vichinsky, E.; Hoppe, C.C.; Ataga, K.I.; More Vichinsky, E.; Hoppe, C.C.; Ataga, K.I.; Ware, R.E.; Nduba, V.; El Beshlawy, A.; Hassab, H.; Achebe, M.M.; Al-Kindi, S.; Brown, C.; Diuguid, D.L.; Telfer, P.; Tsitsikas, D.A.; El Ghandour, A.; Gordeuk, V.R.; Kanter, J.; Abboud, M.R.; Lehrer-Graiwer, J.; Tonda, M.; Intondi, A.; Tong, B.; Howard, J. Less HemaSphere. 3(S1):25-26, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S148 TFR2-HAPLOINSUFFICIENCY ENHANCES THE BENEFICIAL EFFECT OF TMPRSS6-ANTISENSE OLIGONUCLEOTIDE TREATMENT IN BETA-THALASSEMIA MICE Pettinato, M.; Aghajan, M.; Lidonnici, M.R.; More Pettinato, M.; Aghajan, M.; Lidonnici, M.R.; Olivari, V.; Silvestri, L.; Guo, S.; Ferrari, G.; Camaschella, C.; Nai, A. Less HemaSphere. 3(S1):26, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
S149 FIXED-DURATION VENETOCLAX PLUS OBINUTUZUMAB IMPROVES PROGRESSION-FREE SURVIVAL AND MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL AND COMORBIDITIES Fischer, K.; Al-Sawaf, O.; Bahlo, J.; More Fischer, K.; Al-Sawaf, O.; Bahlo, J.; Fink, A.-M.; Tandon, M.; Dixon, M.; Robrecht, S.; Warburton, S.; Humphrey, K.; Samoylova, O.; Liberati, A.M.; Pinilla-Ibarz, J.; Opat, S.; Sivcheva, L.; Le DÛ, K.; Maria Fogliatto, L.; Utoft Niemann, C.; Weinkove, R.; Robinson, S.; Kipps, T.J.; Boettcher, S.; Tausch, E.; Schary, W.L.; Eichhorst, B.; Wendtner, C.-M.; Langerak, A.W.; Kreuzer, K.-A.; Goede, V.; Stilgenbauer, S.; Mobasher, M.; Ritgen, M.; Hallek, M. Less HemaSphere. 3(S1):26-27, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF150 ADAM28 OVEREXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA PROMOTE ITS INVASION IN CENTRAL NEURAL SYSTEM VIA CROSS TALKING WITH CXCR4 PATHWAY Wang, C.; Wang, Y.; Zhang, G.; More Wang, C.; Wang, Y.; Zhang, G.; Su, Y.; Liu, X.; Zhang, J.; Zhang, Y.; Fu, H.; Zhao, X.; Zhao, X.; Chang, Y.; Liu, K.; Huang, X.; Zhang, X. Less HemaSphere. 3(S1):27-28, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF151 RAS/MAPK ACTIVATION COOPERATES WITH GAIN OF CHROMOSOME 21 IN B CELL LEUKEMIA AND IS AN ATTRACTIVE TARGET TO IMPROVE THE OUTCOME OF DS CHILDREN WITH B-ALL Laurent, A.P.; Siret, A.; Ignacimouttou, C.; More Laurent, A.P.; Siret, A.; Ignacimouttou, C.; Diop, M.; Tsai, Y.-C.; Roos-Weil, D.; Plassard, D.; Lagarde, S.; Prade, N.; Aid, H.; Meurice, G.; Bernard, O.; Bonnigal, C. Barin; MacIntyre, E.; Cheung, L.; Kotecha, R.; Bornhauser, B.; Bourquin, J.-P.; Ballerini, P.; Delabesse, E.; Mercher, T.; Malinge, S. Less HemaSphere. 3(S1):28, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF152 XBP1 PROMOTES PRE-B CELL ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH OF IL-7 RECEPTOR SIGNALING IN MICE Salimi, A.; Vieri, M.; Schemionek, M.; More Salimi, A.; Vieri, M.; Schemionek, M.; Huber, M.; Brümmendorf, T.H.; Masouleh, B. Kharabi; Appelmann, I. Less HemaSphere. 3(S1):29, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF153 MLL-AF4 CAUSES ABERRANT UPREGULATION OF PROM1 (CD133) IN ACUTE LYMPHOBLASTIC LEUKEMIA BY CONTROLLING ENHANCER-PROMOTER INTERACTIONS Godfrey, L.; O’Byrne, S.; Crump, N.T.; More Godfrey, L.; O’Byrne, S.; Crump, N.T.; Lau, I.-J.; Thorne, R.; Elliott, N.; Buck, G.; Rice, S.; Connor, C.; Thomas, R.; Cheng, D.; Ancliff, P.; Inglott, S.; Roberts, I.; Roy, A.; Milne, T.A. Less HemaSphere. 3(S1):29, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF155 COMBINATION OF FLOTETUZUMAB, A CD123 X CD3 BISPECIFIC DART® MOLECULE, AND BLINATUMOMAB, A CD19 X CD3 BITE MOLECULE, TO PREVENT ANTIGEN ESCAPE IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA Lukic, D. Slavkovic; Duell, J.; Davidson-Moncada, J.; More Lukic, D. Slavkovic; Duell, J.; Davidson-Moncada, J.; Schlagowsky, A.; Einsele, H.; Szczepanowski, M.; Schewe, D.M.; Brüggemann, M.; Topp, M.S. Less HemaSphere. 3(S1):29-30, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF156 SINGLE-CELL TRANSCRIPTIONAL HETEROGENEITY SUGGESTS NOVEL FINGERPRINT OF RELAPSE IN ACUTE MYELOID LEUKEMIA Wang, Z.; Wang, R.; Yang, C.; More Wang, Z.; Wang, R.; Yang, C.; liu, Y.; Zhang, C.; Gao, L.; Zhang, X. Less HemaSphere. 3(S1):30, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF157 THERAPEUTIC TARGETING OF CYTOKINE INDUCED PIM1 ACTIVATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA Smedt, R. De; Peirs, S.; Trimpont, M. Van; More Smedt, R. De; Peirs, S.; Trimpont, M. Van; Morscio, J.; Roels, J.; Reunes, L.; Lintermans, B.; Lammens, T.; Roy, N. Van; Moerloose, B. De; Benoit, Y.; Meijerink, J.P.; Goossens, S.; Vlierberghe, P. Van Less HemaSphere. 3(S1):30, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF158 TARGETING ONCOGENIC NOTCH1 IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH A NEW SELECTIVE SERCA INHIBITOR CAD204520 Marchesini, M.; Gherli, A.; Winter, A.-M. Lund; More Marchesini, M.; Gherli, A.; Winter, A.-M. Lund; Patrizi, L.; Kitara, S.; Montanaro, A.; Rompietti, C.; Sorrentino, C.; Stilli, D.; Rizzi, F.; Loiacono, C.; Pagliaro, L.; Starza, R. La; Mecucci, C.; Aversa, F.; Sportoletti, P.; Dalby-Brown, W.; Roti, G. Less HemaSphere. 3(S1):31, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF159 COMBINATION OF SELECTIVE GAMMA-SECRETASE INHIBITOR MRK-560 WITH OTHER TARGETED THERAPY IS AN EFFECTIVE AND SAFE TREATMENT FOR T-ALL Govaerts, I.; Gielen, O.; Habets, R.; More Govaerts, I.; Gielen, O.; Habets, R.; de Bock, C.; De Keersmaecker, K.; Segers, H.; Uyttebroeck, A.; Maertens, J.; Boeckx, N.; De Strooper, B.; Cools, J. Less HemaSphere. 3(S1):31, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF160 IKZF1 DELETIONS DO NOT HAVE A STRONG IMPACT ON EVENT FREE SURVIVAL IN PATIENTS WITH B-PRECURSOR ALL TREATED ON THE UKALL14 TRIAL (ISRCTN 66541317) Mitchell, R.J.; Kirkwood, A.A.; Barretta, E.; More Mitchell, R.J.; Kirkwood, A.A.; Barretta, E.; Clifton Hadley, L.; Lawrie, E.; Marks, D.I.; McMillan, A.K.; Tobias, M.; Patrick, P.; Rowntree, C.J.; Wrench, B.; Moorman, A.V.; Fielding, A.K. Less HemaSphere. 3(S1):31-32, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF161 THIOREDOXIN SYSTEM INHIBITORS ARE EFFECTIVE AGAINST B CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN VITRO AND IN VIVO Fidyt, K.; Pastorczak, A.; Goral, A.; More Fidyt, K.; Pastorczak, A.; Goral, A.; Muchowicz, A.; Komorowski, L.; Cyran, J.; Pal, D.; Blair, H.; Burdzinska, A.; Pedzisz, P.; Patkowska, E.; Lech-Maranda, E.; Mlynarski, W.; Golab, J.; Firczuk, M. Less HemaSphere. 3(S1):32-33, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF162 FREQUENCY AND PROGNOSTIC IMPACT OF ZEB2 H1038/Q1072 MUTATIONS IN CHILDHOOD B-OTHER ACUTE LYMPHOBLASTIC LEUKEMIA Zaliova, M.; Potuckova, E.; Lukes, J. Jr.; More Zaliova, M.; Potuckova, E.; Lukes, J. Jr.; Winkowska, L.; Starkova, J.; Janotova, I.; Sramkova, L.; Stary, J.; Zuna, J.; Stanulla, M.; Zimmermann, M.; Bourquin, J.-P.; Eckert, C.; Cario, G.; Trka, J. Less HemaSphere. 3(S1):33, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF163 TARGETING LYSOSOMES AS A POTENTIAL THERAPEUTIC APPROACH FOR T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA Banus Mulet, A.; Cornet-Masana, J.M.; Carbó, J.M.; More Banus Mulet, A.; Cornet-Masana, J.M.; Carbó, J.M.; Cuesta-Casanovas, L.; Guijarro, F.; Esteve, J.; Risueño, R. Less HemaSphere. 3(S1):33-34, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF164 CD9 IS AN ADVERSE PROGNOSTIC MARKER AND PROMISING THERAPEUTIC TARGET IN HIGH-RISK PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA Zhang, C.; Cheung, J.T. K.; Chan, K.Y. Y.; More Zhang, C.; Cheung, J.T. K.; Chan, K.Y. Y.; Wang, H.; Man, T.K. F.; Li, K.; Li, C.K.; Leung, K.T. Less HemaSphere. 3(S1):34, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF165 THE XPO1 INHIBITOR KPT-8602 WORKS SYNERGISTIC WITH DEXAMETHASONE TO INHIBIT ACUTE LYMPHOBLASTIC LEUKEMIA CELLS Verbeke, D.; de Bock, C.; Demeyer, S.; More Verbeke, D.; de Bock, C.; Demeyer, S.; Prieto, C.; De Bie, J.; Gielen, O.; Mentens, N.; Daelemans, D.; Uyttebroeck, A.; Boeckx, N.; De Keersmaecker, K.; maertens, J.; Segers, H.; Cools, J. Less HemaSphere. 3(S1):34-35, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF166 RASD1 INHIBITS THE PROLIFERATION OF LEUKEMIA CELLS AND CORRELATES WITH LEUKEMIA RELAPSE IN ADULTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA Lu, R.-Q.; Wu, L.-X.; Zhang, J.; More Lu, R.-Q.; Wu, L.-X.; Zhang, J.; Qin, Y.-Z.; Liu, Y.-R.; Lai, Y.-Y.; Jiang, H.; Jiang, Q.; Chang, Y.-J.; Ruan, G.-R.; Huang, X.-J. Less HemaSphere. 3(S1):35, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF167 THE TETRASPANIN CD9 REGULATES GLUCOCORTICOID SENSITIVITY IN PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA Li, J.M. H.; Zhang, C.; Cheung, J.T. K.; More Li, J.M. H.; Zhang, C.; Cheung, J.T. K.; Chan, K.Y. Y.; Li, K.; Li, C.K.; Leung, K.T. Less HemaSphere. 3(S1):35-36, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF168 KINASE AND CYTOKINE RECEPTOR SIGNALING PATHWAY ACTIVATING ALTERATIONS IN UNIFORMLY TREATED B-ALL Norvilas, R.; Dirse, V.; Sema-keviciene, R.; More Norvilas, R.; Dirse, V.; Sema-keviciene, R.; Mickeviciute, O.; Vaitkeviciene, G.; Rascon, J.; Griškevicius, L. Less HemaSphere. 3(S1):36, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF169 LONG-TERM INHIBITION OF CHK1/CHK2 KINASES MODIFY ACUTE LYMPHOBLASTIC LEUKEMIA CELL LINE RESPONSE TO DNA DAMAGING AGENTS Ghelli Luserna Di Rora’, A.; Bocconcelli, M.; Padella, A.; More Ghelli Luserna Di Rora’, A.; Bocconcelli, M.; Padella, A.; Fontana, M.C.; Ferrari, A.; Imbrogno, E.; Baldazzi, C.; Testoni, N.; Simonetti, G.; Martinelli, G. Less HemaSphere. 3(S1):36, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF170 ETV6/RUNX1 FUSION GENE ABROGATION DECREASE THE ONCOGENIC POTENCIAL OF TUMORS CELLS IN A PRECLINICAL MODEL OF ACUTE LYMPHOBLASTIC LEUKEMIA Montaño, A.; Ordóñez, J.L.; Alonso-Pérez, V.; More Montaño, A.; Ordóñez, J.L.; Alonso-Pérez, V.; Marín-Quílez, A.; Pérez-Carretero, C.; Benito, R.; García-Tuñón, I.; Hernández-Rivas, J.M. Less HemaSphere. 3(S1):36-37, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF171 DIFFERENTIAL EXPRESSION PATTERNS OF SPECIFIC LONG NONCODING RNAS AND COMPETING ENDOGENOUS RNA NETWORK IN ACUTE LYMPHOCYTE LEUKEMIA Wang, W.; Ma, J.; Gan, S.; More Wang, W.; Ma, J.; Gan, S.; Jiang, Z.; Sun, L.; Sun, H. Less HemaSphere. 3(S1):37, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF172 PROSPECTIVE COMPARISON OF SANGER SEQUENCING VS NEXT GENERATION SEQUENCING FOR ROUTINE BCR-ABL1 KINASE DOMAIN MUTATION SCREENING IN PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS Soverini, S.; Martelli, M.; Bavaro, L.; More Soverini, S.; Martelli, M.; Bavaro, L.; Papayannidis, C.; Sica, S.; Sorà, F.; Albano, F.; Galimberti, S.; Barate’, C.; Rondoni, M.; Abruzzese, E.; Annunziata, M.; Russo, S.; Mannina, D.; Stulle, M.; Imovilli, A.; Curti, A.; Bonifacio, M.; Ferrero, D.; Basilico, C.; Reddiconto, G.; Mineo, G.; Laginestra, M.A.; Pileri, S.A.; Mignone, F.; Percesepe, A.; Martinelli, G.; Cavo, M. Less HemaSphere. 3(S1):37-38, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF173 RESULTS FROM UKALL60+, A UK PHASE 2 STUDY IN ELDERLY PATIENTS WITH UNTREATED ACUTE LYMPHOBLASTIC LEUKAEMIA Morley, N.; Kirkwood, A.; Moorman, A.; More Morley, N.; Kirkwood, A.; Moorman, A.; Clifton-Hadley, L.; Moreira, L.; Rowntree, C.; Wrench, B.; Marwood, E.; Patrick, P.; Snowden, J.A.; Marks, D.I.; Fielding, A.K. Less HemaSphere. 3(S1):38-39, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF174 GERIATRIC ASSESSMENT-BASED TREATMENT OF ELDERLY PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS. RESULTS OF THE GIMEMA LAL1104 PROTOCOL Chiaretti, S.; Cesini, L.; Di Raimondo, F.; More Chiaretti, S.; Cesini, L.; Di Raimondo, F.; Angelucci, E.; Luppi, M.; Bonifacio, M.; Cascavilla, N.; Fozza, C.; La Sala, E.; Soddu, S.; Fazi, P.; Vitale, A.; Foà, R.; Ferrara, F. Less HemaSphere. 3(S1):39, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF175 MULTICENTRE STANDARDIZATION OF MINIMAL RESIDUAL DISEASE DETECTION AND QUANTITATION USING THE EUROCLONALITY-NGS ASSAY Svaton, M.; Fronkova, E.; Kotrova, M.; More Svaton, M.; Fronkova, E.; Kotrova, M.; Reigl, T.; Caye, A.; de Bie, M.; Genuardi, E.; Jelinkova, H.; Lim, E.H.; Nishijima, D.; Pal, K.; Salemi, D.; Sarasquete, M.E.; Songia, S.; Tosi, M.; Villarese, P.; Wakeman, S.; Cave, H.; Cazzaniga, G.; Ferrero, S.; Garcia Sanz, R.; Hancock, J.; Macintyre, E.; Plevova, K.; Sanada, M.; Santoro, A.; Spinelli, O.; van der Velden, V.H.; Yeoh, A.E. J.; Langerak, A.W.; Darzentas, N.; Brüggemann, M.; Trka, J. Less HemaSphere. 3(S1):39-40, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF176 MONOCYTIC SWITCH AND DISCREPANCY BETWEEN FLOW CYTOMETRIC AND MOLECULAR MINIMAL RESIDUAL DISEASE ARE FREQUENT IN DUX4 REARRANGED AND PAX5-P80R MUTATED B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA Novakova, M.; Vakrmanova, B.; Slamova, L.; More Novakova, M.; Vakrmanova, B.; Slamova, L.; Musilova, A.; Bruggemann, M.; Ritgen, M.; Kolenovska, A.; Svec, P.; Fronkova, E.; Kalina, T.; Trka, J.; Stary, J.; Vaskova, M.; Winkowska, L.; Zaliova, M.; Fiser, K.; Hrusak, O.; Mejstrikova, E. Less HemaSphere. 3(S1):40-41, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF177 NATION-WIDE PROSPECTIVE, REAL-TIME MONITORING OF PEGYLATED E.COLI AND ERWINIA ASPARAGINASE THERAPY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA AND NON-HODGKIN LYMPHOMA IN BELGIUM Mondelaers, V.; Lammens, T.; Dedeken, L.; More Mondelaers, V.; Lammens, T.; Dedeken, L.; Uyttebroeck, A.; Brichard, B.; van der Werff ten Bosch, J.; Norga, K.; Francotte, N.; Piette, C.; Benoit, Y.; De Moerloose, B. Less HemaSphere. 3(S1):41, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF178 DEFINITION OF REPRESENTATIVE BONE MARROW SAMPLE BASED ON PARALLEL EVALUATION OF PERIPHERAL BLOOD DURING THE THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA Vakrmanova, B.; Novakova, M.; Stary, J.; More Vakrmanova, B.; Novakova, M.; Stary, J.; Hrusak, O.; Mejstrikova, E. Less HemaSphere. 3(S1):41, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF179 DIFFERENT IMPACT OF BCR BREAKPOINT ON THE OUTCOME OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FROM DIFFERENT GRAFT SOURCE FOR PH+ALL IN THE ERA OF TKI Nishiwaki, S.; Mizuta, S.; Ohashi, K.; More Nishiwaki, S.; Mizuta, S.; Ohashi, K.; Fukuda, T.; Uchida, N.; Kanamori, H.; Onizuka, M.; Ozawa, Y.; Tanaka, J.; Ichinohe, T.; Atsuta, Y.; Kako, S. Less HemaSphere. 3(S1):42, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF180 THE SIGNIFICANCE OF MONOSOMAL KARYOTYPE IN PHILADELPHIA CHROMOSOME NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA Li, Z.; Jiang, Q.; Lai, Y.; More Li, Z.; Jiang, Q.; Lai, Y.; Zhang, X.; Xu, L.; Liu, K.; Wang, Y.; Jiang, H.; Huang, X. Less HemaSphere. 3(S1):42, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF181 PEDIATRIC-INSPIRED REGIMEN PLUS HDACI CHIDAMIDE YIELDED PROMISING RESPONSE IN PH-LIKE AND ETP ACUTE LYMPHOBLASTIC LEUKEMIA Zhou, H.; Gao, Y.; Wang, Q.; More Zhou, H.; Gao, Y.; Wang, Q.; Cao, R.; Yin, C.; Zhou, X.; Li, Q.; He, X.; Huang, K.; Liu, N.; Lin, D.; Liu, X.; Liu, Q. Less HemaSphere. 3(S1):42-43, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF182 CLINICOBIOLOGIC CHARACTERISTICS AND OUTCOME OF ELDERLY FRAIL PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA INCLUDED IN A SPECIFIC PROTOCOL (ALL-07FRAIL) Ribera, J.M.; García-Calduch, O.; Gil, C.; More Ribera, J.M.; García-Calduch, O.; Gil, C.; González-Campos, J.; Moreno, M.J.; Barba, P.; Amigo, M.L.; Martínez-Carballeira, D.; Alonso, N.; Bergua, J.M.; Mercadal, S.; Cladera, A.; Vall-Llovera, F.; García-Guiñón, A.; López, A.; Lavilla, E.; Sierra, M.; Hernández-Rivas, J.M. Less HemaSphere. 3(S1):43, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF183 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN CHILDREN WITH HEMATOLOGHIC AND ONCOLOGIC DISEASES: MULTICENTER EXPERIENCE Arman Bilir, O.; Dikme, G.; Malbora, B.; More Arman Bilir, O.; Dikme, G.; Malbora, B.; Evim, M.S.; OnderSivis, Z.; Tufekci, O.; Bahadir, A.; Karaman, S.; Vural, S.; Bayhan, T.; Celkan, T.; Ozbek, N.Y. Less HemaSphere. 3(S1):43-44, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF184 EFFICACY OF CONSOLIDATION CHEMOTHERAPY FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WHO ACHIEVED COMPLETE REMISSION BY FIRST COURSE OF REMISSION INDUCTION THERAPY Shigematsu, A.; Ota, S.; Kobayashi, R.; More Shigematsu, A.; Ota, S.; Kobayashi, R.; Kondo, T.; Endo, T.; Tsutsumi, Y.; Kobayashi, H.; Kakinoki, Y.; Yamamoto, S.; Konuma, Y.; Miyagishima, T.; Igarashi, T.; Oda, T.; Sakai, H.; Ishihara, T.; Yoshida, M.; Nagashima, T.; Sato, K.; Kanisawa, Y.; Haseyama, T.; Hirayama, Y.; Kurosawa, M. Less HemaSphere. 3(S1):44, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF185 WT1 OVEREXPRESSION PREDICTED GOOD OUTCOMES IN ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS RECEIVING CHEMOTHERAPY Wang, S.; Wang, C.; Li, T.; More Wang, S.; Wang, C.; Li, T.; Wang, W.; Hao, Q.; Xie, X.; Wan, D.; Jiang, Z.; Liu, Y. Less HemaSphere. 3(S1):44-45, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF186 INTENSIVE CARE OF THE LIFE –THREATING COMPLICATION DE NOVO ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS (PTS) Bazhenov, A.; Galstyan, G.; Parovichnikova, E.; More Bazhenov, A.; Galstyan, G.; Parovichnikova, E.; Troitskaya, V. Less HemaSphere. 3(S1):45, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF187 LEUKEMIA AND DEPLETED URANIUM IN KOSOVO Latifi-Pupovci, H.; Selmonaj, M.; Ahmetaj-Shala, B.; More Latifi-Pupovci, H.; Selmonaj, M.; Ahmetaj-Shala, B.; Dushi, M.; Grajqevci, V. Less HemaSphere. 3(S1):45-46, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF188 NGS COMBINED WITH ASO REAL-TIME PCR BASED MRD DETECTION ASSAY FOR PEDIATRIC ALL PATIENTS Nicolaou, K.; Chi, J.; Koumas, L.; More Nicolaou, K.; Chi, J.; Koumas, L.; Loizou, L.; Karaoli, E.; Papachristodoulou, E.; Loizos, A.; Costeas, P. Less HemaSphere. 3(S1):46, June 2019. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Free
PF189 APPROPRIATE INTERVAL OF MONITORING FOR DETECTION OF MOLECULAR RELAPSE AFTER STOP OF TKI IN PH+ALL IN PH+ ALL CALCULATING BY MRD KINETICS Miyamura, K.; Morishita, T.; Goto, T.; More Miyamura, K.; Morishita, T.; Goto, T.; Nishiwaki, S.; Ozawa, Y. Less HemaSphere. 3(S1):46-47, June 2019. Abstract Abstract Favorites
